Ticker

Disclosure of transactions in own shares Paris, France (March 2, 2026 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders' Meeting on April 30, 2025, EssilorLuxottica declares that on February 27, 2026, the following share buybacks were carried out: Name of the issuer Identity code of the issuer Day of the transaction Identity code of the financial instrument Total daily volume (in…

Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two stocks offers value investors a better bang for their buck right now?

EssilorLuxottica CFO Stefano Grassi discusses demand for AI glasses and the company's business model in an exclusive interview.

Disclosure of transactions in own shares Paris, France (February 16, 2026 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders' Meeting on April 30, 2025, EssilorLuxottica declares that on February 13, 2026, the following share buybacks were carried out: Name of the issuer Identity code of the issuer Day of the transaction Identity code of the financial instrument Total daily volume…

EssilorLuxottica delivered robust Q4 and FY 2025 results, with FY sales reaching €28.49 billion, up 11.4% year-over-year. Strong double-digit growth in smart glasses and innovation-driven categories positions the company as a high-quality compounder with structural upside potential. Management shifts focus from rigid margin targets to growth, emphasizing smart eyewear, hearing solutions, and myopia management as key…